Based on this STMN1 expression and phosphorylation (STMN1-E/P) model, we assessed the prognostic accuracy of the risk score with a time-dependent ROC analysis, it trended towards a higher prognostic accuracy than TNM staging, a traditional prognostic classifier for cancer patients (AUC for STMN1-E/P model: 0.719; AUC for TNM staging: 0.658; Figure 2A). Here, STMN1 is linked to cancer.